Cargando…
In Vitro Susceptibility of Iranian Isolates of Trichomonas vaginalis to Metronidazole
BACKGROUND: Metronidazole, a 5-nitroimidazole derivative, is the main antitrichomonal agent of choice for treatment of trichomoniasis. Since 1962, some cases of treatment failure with metronidazole have been reported and recently drug resistance is now on the rise in the world. This study was aimed...
Autores principales: | MATINI, Mohammad, MAGHSOOD, Amir-Hossein, MOHEBALI, Mahdi, RABIEE, Soghra, FALLAH, Mohammad, REZAIE, Sassan, REZAEIAN, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835469/ https://www.ncbi.nlm.nih.gov/pubmed/27095968 |
Ejemplares similares
-
Genetic Identification of Trichomonas vaginalis by Using the Actin Gene and Molecular Based Methods
por: MATINI, Mohammad, et al.
Publicado: (2014) -
Prevalence of Trichomonas vaginalis Infection in Hamadan City, Western Iran
por: Matini, M, et al.
Publicado: (2012) -
Genotyping, Drug Susceptibility and Prevalence Survey of Trichomonas vaginalis among Women Attending Gynecology Clinics in Hamadan, Western Iran, in 2014–2015
por: MATINI, Mohammad, et al.
Publicado: (2017) -
Comparison of Resistant and Susceptible Strains of Trichomons vaginalis to Metronidazole Using PCR Method
por: Rabiee, S, et al.
Publicado: (2012) -
In Vitro Activity of Foeniculum vulgare and Its Main Essential Oil Component Trans-Anethole on Trichomonas vaginalis
por: KARAMI, Faezeh, et al.
Publicado: (2019)